Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Expandable, Functional Hepatocytes Derived from Primary Cells Enable Liver Therapeutics

December 2024 Bioprinting, Cell Therapy, Clinical, Drug Screening, Tissue Engineering

Lab-grown, 3D Extracellular Matrix Particles Improve Cardiac Function and Morphology in Myocardial Ischemia

December 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Good Manufacturing Practice-grade fibronectin for hollow-fiber bioreactor cell manufacture: a mesenchymal stromal cell case study

December 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing, Tissue Engineering

Decellularized Extracellular Matrix Improves Mesenchymal Stromal Cell Spheroid Response to Chondrogenic Stimuli

November 2024 Bioprinting, Bioprocessing, Cardiovascular, Exosomes / Extracellular Vesicles, Orthopedic, Tissue Engineering

Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles

November 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

The proteomic landscape of extracellular vesicles derived from human intervertebral disc cells

November 2024 Bioprinting, Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Pain, Tissue Engineering

Evaluating the Immunomodulatory Activity of Extracellular Vesicles Released from Enhanced Adipose Tissue-Derived Mesenchymal Stromal Cells

November 2024 Bioprinting, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Stepwise Stiffening/Softening of and Cell Recovery from Reversibly Formulated Hydrogel Interpenetrating Networks

November 2024 Bioprinting, Cancer, Exosomes / Extracellular Vesicles, Gene Editing, MedTech, Devices, & Materials, Tissue Engineering

A Bioactive Hydrogel Based on Notochordal Cell-Derived Matrix Stimulates Nucleus Pulposus Regeneration

October 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Dermal and Wound, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Pain, Tissue Engineering

Shaping the mechanical properties of a gelatin hydrogel interface via amination

October 2024 Bioprinting, Bioprocessing, Cell Therapy, MedTech, Devices, & Materials, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 … 24 25 26 27 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email